Recent studies showed decreased expression of carboxylesterase 2 (CES2) in the liver of NASH patients and hepatic DAG accumulation was linked to low CES2 activity in obese individuals. The gene discussed is CES2; the disease is metabolic dysfunction-associated steatohepatitis.